Risk factor
Very high price volatility
Profitability factor
Very favourable analyst view
About
Inner Mongolia Furui Medical Science Co., Ltd. functions as a dedicated platform offering specialized healthcare services. The company's primary focus lies in the liver disease sector, where it delivers a full spectrum of solutions encompassing accurate disease diagnosis, pharmaceutical treatments, and ongoing chronic condition management. Beyond this, it also provides comprehensive health management facilities and general medical care services. Established in 1998, with its headquarters situated in Beijing, China, the entity was previously known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB
Target Price
The average target price of 300049.SZ is 70.0 and suggests 80.2% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to